20 December 2016

The theme of Cancer development and immune defense will organize a new Cancer Immunology & Immunotherapy meeting within the Radboudumc. The frequency of this meeting will be 4 times per year in January, March, June and October.

For the year 2017, we have made an exciting meeting program with presentations discussing new unpublished data within specific topics in the CII field. After the presentations and discussions there is time for networking and setting up potential collaborations. 

Please find attached the announcement and 2017 meeting program, and pass it on to people who may be interested. 

We hope to see you all !

Related news items


Ignacio Malagon, first professor of Pediatric Anaesthesiology in the Netherlands

21 January 2019

Ignacio Malagon has been appointed professor of Pediatric Anaesthesiology at Radboud University / Radboud university medical center with effect from 1 January 2019. He is the first professor in this field in the Netherlands.

read more

Thomas Maal appointed full professor of 3D Technology in Healthcare

7 January 2019

3D technology leads to better care and lower costs.

read more

Quickly detecting actual heart attacks prevents unnecessary hospital visits Research by Radboud university medical center improves efficacy and reduces cost of cardiac care

4 January 2019

Many patients who suffer from chest pain are not actually having a heart attack, making an emergency hospital visit unnecessary. Is there a way to quickly and accurately determine at home whether emergency hospital treatment is necessary?

read more

Radboud university medical center treats metastatic liver cancer with holmium microspheres MRI imaging during surgery can improve the outcome

4 January 2019

For the first time Radboud university medical center has treated a patient with liver metastases by using holmium radio-embolization. With this technique, radioactive holmium microspheres are injected via a catheter into the liver artery.

read more

Research into drugs for treating rare diseases can be more efficient and patient-oriented

18 December 2018

To assess whether a drug is an effective treatment for a rare disease, large-scale research with Randomized Controlled Trials may not be necessary in all situations, say researchers from the departments of Neurology and Health Evidence in the Journal of the American Medical Association (JAMA).

read more